Most analysts expect a filing in late 2027 at the earliest, with potential approval in 2028
4 A randomised, double blind placebo controlled trial on 54 healthy adults assessed glutathione levels at one, three and six months
While marketed as an anti-aging therapy, more robust studies are needed to validate these claims
Boosts Energy and Productivity: Provides critical support during fatigue, low-performance periods, pregnancy, and post-birth stages in newborns
In preclinical studies, BPC-157 has shown to have a positive impact when treating conditions such as inflammatory bowel disease, traumatic brain injury, and arthritis [5]
Furthermore, considering the persistent oxidative stress and neuroinflammatory processes that often follow sTBI, patients are also likely to benefit from the continued use of NAC (Figure 1)